Approved Use

Repatha® is an injectable prescription medicine called a PCSK9 inhibitor. Repatha® is used:

  • along with diet and maximally tolerated statin therapy in adults with Read more heterozygous familial hypercholesterolemia (an inherited condition that causes high levels of LDL) or atherosclerotic heart or blood vessel problems, who need additional lowering of LDL cholesterol. Read more

The effect of Repatha® on heart problems, such as heart attacks, stroke, or death, has not been determined.

RepathaReady® Text Message Reminder

Program Overview
Mobile Terms and Conditions

Once enrolled in RepathaReady®—the Repatha® Patient Support Program, Repatha® patients can sign up for helpful medication reminders. These reminders can be delivered through email or text message. Patients can choose to receive reminders for prescription refills, reminders that it’s time to take Repatha®, or both.

Enrollment and Getting Started:

At this time, enrollment for the text medication reminder program can only be completed online at Repatha.com.

Within the medication reminder program registration section on Repatha.com, specific to the text message option, patients will be asked to provide the following information:

  • Cell Phone number—This is the number where the patient would like the medication reminders to be delivered
  • Time Zone—This is important to provide so the text messages are delivered at an appropriate time of day

At the time of registration, patients can also view the Mobile Terms & Conditions, which is also included on this page.

Once a patient enrolls in RepathaReady® and chooses to receive medication reminders, specific to the text medication reminder program option, patients will receive a welcome text message from 72328 confirming their desire to enroll in the Repatha® medication text reminder program. The patient will need to reply ‘YES’ to confirm enrollment. Should the patient not confirm enrollment, they will not be enrolled in receiving text medication reminders for Repatha®. See below for message example:

Depending upon the patient provided information on how often they take Repatha®, and how often they refill their Repatha® prescription, text medication reminders will be sent based on that timing and the date provided as to when he/she wants to receive their first reminder. For example:

  • Patient selects: Taking Repatha® every 2 weeks + first dose reminder: June 1 = First dose reminder text will be sent to patient June 1 and every 14 days thereafter.
  • Patient selects: Refilling Repatha® every 30 days + first refill reminder: June 1 = First refill reminder text will be sent to the patient June 1 and every 30 days thereafter.

How Many Text Messages Will Patients Receive?

The amount of text medication reminders received by the patient will vary per month based on their registration preference. On average, a patient may receive 2-4 messages per month.

Opting Out:

A patient can opt out of the RepathaReady® medication reminder program at any time by calling 1-844-REPATHA (1-844-737-2842).

Customer Support:

Should the patient have any questions about Repatha® or the RepathaReady® Patient Support Program, please do not reply to any text message sent to you through the reminder program, as responses are not monitored. Instead, please call 1-844-REPATHA (1-844-737-2842) and a helpful RepathaReady® representative can help assist you.

Amgen’s Repatha® Reminders mobile Short Message Service (SMS) program runs on the short code 72328. Amgen will not charge you to use this Service, however your Wireless Service Provider may charge for sending and/or receiving messages and for airtime.

Amgen Inc. ("Amgen") reserves the right, in its sole discretion, to change, modify, add, or remove these Mobile Terms of Use ("Mobile Terms") at any time. Amgen may in its discretion change or suspend the Service (defined below) at any time. If you are dissatisfied with the Service or the content received through the Service, your sole remedy is to discontinue use of the Service.

By using the Service and accepting these terms, you also agree to Amgen’s standard Terms of Use, incorporated herein by reference. In the event of a conflict between the standard Terms of Use and these mobile terms, these Mobile Terms shall prevail.

Mobile Service:

  1. Amgen provides SMS health alerts and medication reminders as Repatha® Reminders (collectively, the ‘Service’). Please note that to process your requests for this Service, you may be charged a fee to send and receive messages based on the terms of your wireless service agreement. All charges are billed by and payable to your Wireless Service Provider. Check with your Wireless Service Provider if you have questions about your wireless service plan.
  2. Amgen will not be liable for any delays in the receipt of any SMS messages as delivery is subject to effective transmission from your Wireless Service Provider.
  3. This Service is available on the following carriers: AT&T, Verizon Wireless, Sprint, Virgin Mobile, Boost, T-Mobile, MetroPCS, U.S. Cellular, Cricket Wireless, Google Voice, nTelos, Alaska Communications Systems (ACS), bandwidth.com (includes Republic Wireless), Bluegrass Cellular, Boost-CDMA, C Spire Wireless (Cellular South), CableVision, Carolina West Wireless, CellCom, Cellular One of N.E. Arizona, Chariton Valley Cellular, Chat Mobility, Cleartalk (Flat Wireless), Copper Valley Telecom, DTC Wireless, Duet Wireless, East Kentucky Network (Appalachian Wireless), ECIT/Cellular One of East Central Illinois, GCI Communications, Illinois Valley Cellular, Inland Cellular, IWireless, Leaco Rural Telephone Cooperative, Limitless Mobile, Mid-Rivers Communications, Mobi PCS, MobileNation/SI Wireless, MTA Wireless/Matanuska Kenai, MTPCS Cellular One (Cellone Nation), Nemont US UMTS, Nex Tech Communications, Northwest Missouri Cellular, Panhandle Wireless, Pine Cellular, Pioneer Cellular, Plateau Wireless, Rural Independent Network Alliance (RINA), Sagebrush, SouthernLINC, SRT Communications, Thumb Cellular, TracFone, Union Telephone, United Wireless, Viaero Wireless, and West Central Wireless. T-Mobile is not liable for delayed or undelivered messages.
  4. For additional questions, please call 1-844-737-2842.

Privacy Policy:

For Amgen privacy practices, please see our Privacy Policy.

Service Details:

Visit Repatha.com or call 1-844-737-2842 to subscribe to Repatha® Reminders SMS health alerts and medication reminders. You will receive a maximum of 4 messages per month. Text HELP to 72328 for help, STOP to 72328 to cancel. Message and Data Rates May Apply.


TO OPT-IN TO REPATHA® REMINDERS OR RECEIVE SUBSCRIPTION MESSAGES:
Visit Repatha.com or call 1-844-737-2842 to enroll. Provide the required information including your mobile phone number. You will receive an opt-in request from 72328 to your mobile phone number. Follow the texting prompts to complete your subscription.

EXAMPLE RESPONSE FROM 72328:
Repatha(R) (evolocumab): Reminders to take & to refill Repatha(R) will be sent based on your schedule (2-4 msgs/mo). To update your schedule call 1-844-737-2842.

TO STOP (OPT-OUT OF) THE SERVICE ON 72328:
You can cancel receipt of all SMS messages from 72328 by replying to any Service message, or sending ‘STOP‘, ‘END‘, ‘QUIT‘, ‘UNSUBSCRIBE‘, or ‘CANCEL‘ to 72328.

EXAMPLE STOP MESSAGE:
Repatha(R) (evolocumab): You will no longer receive text msgs from the Repatha(R) reminder program or 72328. For information about Repatha, visit Repatha.com.

TO GET HELP ON THE SERVICE ON 72328:
You can get HELP, by replying to any Service message, or sending ‘HELP’ to 72328. You can also call 1-844-737-2842 for more information.

EXAMPLE HELP MESSAGE:
Repatha(R) (evolocumab): For questions on the Repatha(R) reminder program or to update your schedule call 1-844-737-2842 from 9AM–11PM EST.

Important Safety Information and Approved Use

Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.

Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including allergies, and if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. The needle covers on the single-use prefilled syringes and the inside of the needle caps on the single-use prefilled SureClick® autoinjectors contain dry natural rubber. The single-use Pushtronex® system (on-body infusor with prefilled cartridge) is not made with natural rubber latex.

Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines you are taking or plan to take, including natural or herbal remedies.

What are the possible side effects of Repatha®?

Repatha® may cause allergic reactions. Call your healthcare provider or go to the nearest hospital emergency room right away if you have any symptoms of an allergic reaction including a severe rash, redness, severe itching, a swollen face, or trouble breathing.

The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, and redness, pain, or bruising at the injection site.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of Repatha®. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Approved Use

Repatha® is an injectable prescription medicine called a PCSK9 inhibitor. Repatha® is used:

The effect of Repatha® on heart problems, such as heart attacks, stroke, or death, has not been determined.

Important Safety Information and Approved Use

Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.

Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including allergies, and if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. The needle covers on the single-use prefilled syringes and the inside of the needle caps on the single-use prefilled SureClick® autoinjectors contain dry natural rubber. The single-use Pushtronex® system (on-body infusor with prefilled cartridge) is not made with natural rubber latex.

Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines you are taking or plan to take, including natural or herbal remedies.

What are the possible side effects of Repatha®?

Repatha® may cause allergic reactions. Call your healthcare provider or go to the nearest hospital emergency room right away if you have any symptoms of an allergic reaction including a severe rash, redness, severe itching, a swollen face, or trouble breathing.

The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, and redness, pain, or bruising at the injection site.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of Repatha®. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Approved Use

Repatha® is an injectable prescription medicine called a PCSK9 inhibitor. Repatha® is used:

  • along with diet and maximally tolerated statin therapy in adults with heterozygous familial hypercholesterolemia (an inherited condition that causes high levels of LDL) or atherosclerotic heart or blood vessel problems, who need additional lowering of LDL cholesterol.

The effect of Repatha® on heart problems, such as heart attacks, stroke, or death, has not been determined.